Associations of Maternal Fructosamine before Delivery in Gestational Diabetes Mellitus Pregnancies with Neonatal Glucometabolic Disorders

Table 1

The baseline demographic characteristics of GDM pregnant women with different levels of FMN_ALB before delivery.

	()	()
Gestational age ()			0.51	0.61
Birth weight ()			1.27	0.21
Maternal age (years)			-0.60	0.55
75 g glucose OGTT
Fasting blood glucose (mmol/L)			0.03	0.98
1 h after glucose load (mmol/L)			-0.03	0.98
2 h after glucose load (mmol/L)			-0.30	0.76
Apgar , (, %)	, 16.67%	, 17.68%	0.04	0.85
Apgar , (, %)	, 3.03%	, 3.54%	0.04	0.84
Placenta previa or abruption, (, %)	, 12.12%	, 15.15%	0.37	0.54
III degrees or meconium-stained amniotic fluid, (, %)	, 16.67%	, 15.15%	0.09	0.77
Antenatal corticosteroid use, (, %)	, 21.21%	, 18.18%	0.30	0.59
Insulin use during pregnancy, (, %)	, 16.67%	, 17.68%	0.04	0.85

GDM: gestational diabetes mellitus; FMN_ALB: the ratio of fructosamine to plasma albumin.